Squarepoint Ops LLC Adc Therapeutics Sa Transaction History
Squarepoint Ops LLC
- $99.2 Billion
- Q4 2024
A detailed history of Squarepoint Ops LLC transactions in Adc Therapeutics Sa stock. As of the latest transaction made, Squarepoint Ops LLC holds 107,231 shares of ADCT stock, worth $171,569. This represents 0.0% of its overall portfolio holdings.
Number of Shares
107,231
Previous 75,392
42.23%
Holding current value
$171,569
Previous $237,000
10.13%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ADCT
# of Institutions
85Shares Held
53.5MCall Options Held
28KPut Options Held
60.4K-
Redmile Group, LLC San Francisco, CA15.7MShares$25.1 Million2.44% of portfolio
-
Prosight Management, LP Dallas, TX9.52MShares$15.2 Million5.62% of portfolio
-
Orbimed Advisors LLC San Diego, CA5.97MShares$9.55 Million0.32% of portfolio
-
Morgan Stanley New York, NY3.96MShares$6.33 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$5.69 Million0.0% of portfolio
About ADC Therapeutics SA
- Ticker ADCT
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,645,296
- Market Cap $124M
- Description
- ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...